ArticleThe Biochemical journal2026

A mitochondrial amidoxime-reducing component 1 (mARC1) A168T amino acid substitution does not confer protection from MASH and fibrosis in multiple mouse models of chronic liver disease.

Sentibel Pandovski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.